A First-in-Human Study of BG-C137, an Anti-FGFR2b Antibody Drug Conjugate, in Participants With Advanced Solid Tumors

RECRUITING

Seoul National University Bundang Hospital, BundangGu SeongnamSi

NOT_YET_RECRUITING

Gachon University Gil Medical Center, NamdongGu

NOT_YET_RECRUITING

Kyungpook National University Chilgok Hospital, BukGu

RECRUITING

Beijing Cancer Hospital, Beijing

RECRUITING

Affiliated Zhongshan Hospital of Fudan University, Shanghai

RECRUITING

Shanghai East Hospital Branch Hospital, Shanghai

NOT_YET_RECRUITING

The Affiliated Hospital of Qingdao University Branch North, Qingdao

RECRUITING

Hubei Cancer Hospital, Wuhan

RECRUITING

Usc Norris Comprehensive Cancer Center (Nccc), Los Angeles

RECRUITING

Yale Cancer Center, New Haven

RECRUITING

Mayo Clinic Rochester, Rochester

RECRUITING

Md Anderson Cancer Center, Houston

RECRUITING

Fred Hutchinson Cancer Research Center, Seattle

RECRUITING

University of Wisconsin, Madison

RECRUITING

Blacktown Cancer and Haematology Centre, Blacktown

RECRUITING

Liverpool Hospital, Liverpool

RECRUITING

Icon Cancer Centre South Brisbane, South Brisbane

RECRUITING

Monash Health, Clayton

RECRUITING

Cabrini Hospital Malvern, Malvern East

RECRUITING

Samsung Medical Center, GangnamGu

RECRUITING

Severance Hospital Yonsei University Health System, SeodaemunGu

RECRUITING

Seoul National University Hospital, Seoul

NOT_YET_RECRUITING

Gangnam Severance Hospital, Yonsei University Health System, Seoul

RECRUITING

Asan Medical Center, SongpaGu